2,439 Shares in Intuitive Surgical, Inc. $ISRG Acquired by SBI Okasan Asset Management Co.Ltd.

SBI Okasan Asset Management Co.Ltd. acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, Holdings Channel reports. The firm acquired 2,439 shares of the medical equipment provider’s stock, valued at approximately $1,403,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Holos Integrated Wealth LLC acquired a new position in Intuitive Surgical in the 4th quarter worth approximately $25,000. Newbridge Financial Services Group Inc. boosted its stake in Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the period. Greykasell Wealth Strategies Inc. purchased a new stake in Intuitive Surgical in the 3rd quarter worth approximately $27,000. Olistico Wealth LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $28,000. Finally, Caitlin John LLC purchased a new stake in Intuitive Surgical in the 3rd quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.2%

NASDAQ:ISRG opened at $423.63 on Friday. Intuitive Surgical, Inc. has a 1 year low of $414.30 and a 1 year high of $603.88. The firm’s fifty day simple moving average is $454.60 and its 200 day simple moving average is $507.01. The firm has a market capitalization of $150.03 billion, a PE ratio of 51.35, a PEG ratio of 3.34 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. During the same period last year, the business posted $1.81 EPS. Intuitive Surgical’s revenue was up 23.0% compared to the same quarter last year. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Truist Financial cut their target price on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research report on Wednesday, April 15th. Piper Sandler cut their target price on shares of Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Mizuho set a $525.00 price target on shares of Intuitive Surgical and gave the company a “neutral” rating in a report on Monday, April 13th. HSBC cut their price target on shares of Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Finally, TD Cowen cut their price target on shares of Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Nineteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $576.71.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical announced Taylor Patton will become Chief Commercial and Marketing Officer effective July 1, while current commercial chief Henry Charlton moves to SVP of Global Business Operations. The change appears to be an internal promotion, suggesting leadership continuity rather than disruption. Article Title
• Positive Sentiment: The company has also highlighted major updates to its da Vinci 5 robotic surgical system, with more than 100 improvements set to roll out to U.S. customers starting in June. Investors may view that as a sign of continued innovation and potential to support procedure growth. Article Title
• Positive Sentiment: Recent commentary from market and research outlets has remained favorable, with articles arguing that Intuitive Surgical’s above-average financial growth and optimistic analyst outlook could make the stock attractive to growth investors. Article Title
• Neutral Sentiment: A market note said Intuitive Surgical underperformed competitors on Wednesday, but the item did not point to a company-specific setback or new fundamental issue. Article Title

Insider Activity

In related news, EVP Myriam Curet sold 105 shares of the firm’s stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Mark Brosius sold 2,362 shares of the firm’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the completion of the transaction, the senior vice president owned 3,554 shares in the company, valued at $1,772,308.72. The trade was a 39.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 5,481 shares of company stock valued at $2,673,871. 0.60% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.